Gain Therapeutics Inc (GANX)
2.96
+0.03
(+1.02%)
USD |
NASDAQ |
May 03, 16:00
2.93
-0.03
(-1.01%)
After-Hours: 20:00
Gain Therapeutics Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
Eli Lilly and Co | 22.48% |
Alpine Immune Sciences Inc | 97.33% |
Outlook Therapeutics Inc | 98.82% |
OptiNose Inc | 94.79% |
Greenwich LifeSciences Inc | -- |